Unknown

Dataset Information

0

Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C.


ABSTRACT: Cerebral elevation of 42-residue amyloid ?-peptide (A?42) triggers neuronal dysfunction in Alzheimer's disease (AD). Even though a number of cholesterol modulating agents have been shown to affect A? generation, the role of cholesterol in the pathogenesis of AD is not clear yet. Recently, we have shown that increased membrane cholesterol levels downregulates phosphatidylinositol 4,5-bisphosphate (PIP2) via activation of phospholipase C (PLC). In this study, we tested whether membrane cholesterol levels may affect the A?42 production via changing PIP2 levels. Increasing membrane cholesterol levels decreased PIP2 and increased secreted A?42. Supplying PIP2, by using a PIP2-carrier system, blocked the effect of cholesterol on A?42. We also found that cholesterol increased the expressions of ?1 and ?3 PLC isoforms (PLC?1, PLC?3). Silencing the expression of PLC?1 prevented the effects of cholesterol on PIP2 levels as well as on A?42 production, suggesting that increased membrane cholesterol levels increased secreted A?42 by downregulating PIP2 via enhancing the expression of PLC?1. Thus, cholesterol metabolism may be linked to A?42 levels via PLC?1 expression and subsequent changes in PIP2 metabolism.

SUBMITTER: Chun YS 

PROVIDER: S-EPMC4437359 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Increasing Membrane Cholesterol Level Increases the Amyloidogenic Peptide by Enhancing the Expression of Phospholipase C.

Chun Yoon Sun YS   Oh Hyun Geun HG   Park Myoung Kyu MK   Kim Tae-Wan TW   Chung Sungkwon S  

Journal of neurodegenerative diseases 20130307


Cerebral elevation of 42-residue amyloid β-peptide (Aβ42) triggers neuronal dysfunction in Alzheimer's disease (AD). Even though a number of cholesterol modulating agents have been shown to affect Aβ generation, the role of cholesterol in the pathogenesis of AD is not clear yet. Recently, we have shown that increased membrane cholesterol levels downregulates phosphatidylinositol 4,5-bisphosphate (PIP2) via activation of phospholipase C (PLC). In this study, we tested whether membrane cholesterol  ...[more]

Similar Datasets

| S-EPMC3989356 | biostudies-literature
| S-EPMC7038105 | biostudies-literature
| S-EPMC3907210 | biostudies-literature
| S-EPMC7145019 | biostudies-literature
| S-EPMC3465494 | biostudies-literature
| S-EPMC4280040 | biostudies-literature
| S-EPMC11288891 | biostudies-literature
| S-EPMC9322353 | biostudies-literature
2022-05-31 | GSE201052 | GEO
| S-EPMC5461824 | biostudies-literature